Schirinzi T - Search Results

1

Movement disorders in ADAR1 disease: Insights from a comprehensive cohort.

Di Lazzaro G, Graziola F, Sancesario A, Insalaco A, Moneta GM, Castelli E, Bertini E, Travaglini L, Stregapede F, Capuano A, Vasco G, Schirinzi T. Di Lazzaro G, et al. Among authors: schirinzi t. Parkinsonism Relat Disord. 2020 Oct;79:100-104. doi: 10.1016/j.parkreldis.2020.08.039. Epub 2020 Aug 30. Parkinsonism Relat Disord. 2020. PMID: 32911246 Review.

2

Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD).

Schirinzi T, Di Lorenzo F, Ponzo V, Palmieri MG, Bentivoglio AR, Schillaci O, Pisani A, Koch G. Schirinzi T, et al. Parkinsonism Relat Disord. 2016 Jul;28:23-8. doi: 10.1016/j.parkreldis.2016.03.023. Epub 2016 Apr 1. Parkinsonism Relat Disord. 2016. PMID: 27170027

3

Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study.

Schirinzi T, Martella G, D'Elia A, Di Lazzaro G, Imbriani P, Madeo G, Monaco L, Maltese M, Pisani A. Schirinzi T, et al. Parkinsons Dis. 2016;2016:9646057. doi: 10.1155/2016/9646057. Epub 2016 Aug 29. Parkinsons Dis. 2016. PMID: 27651975 Free PMC article.

4

Rotigotine may control drooling in patients with Parkinson's Disease: Preliminary findings.

Schirinzi T, Imbriani P, D'Elia A, Di Lazzaro G, Mercuri NB, Pisani A. Schirinzi T, et al. Clin Neurol Neurosurg. 2017 May;156:63-65. doi: 10.1016/j.clineuro.2017.03.012. Epub 2017 Mar 18. Clin Neurol Neurosurg. 2017. PMID: 28342306

5

Assessment of serum uric acid as risk factor for tauopathies.

Schirinzi T, Di Lazzaro G, Colona VL, Imbriani P, Alwardat M, Sancesario GM, Martorana A, Pisani A. Schirinzi T, et al. J Neural Transm (Vienna). 2017 Sep;124(9):1105-1108. doi: 10.1007/s00702-017-1743-6. Epub 2017 Jun 15. J Neural Transm (Vienna). 2017. PMID: 28620833

6

Promising rodent models in Parkinson's disease.

Imbriani P, Sciamanna G, Santoro M, Schirinzi T, Pisani A. Imbriani P, et al. Among authors: schirinzi t. Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S10-S14. doi: 10.1016/j.parkreldis.2017.07.027. Epub 2017 Jul 27. Parkinsonism Relat Disord. 2018. PMID: 28760592 Review.

7

Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease.

Schirinzi T, Di Lazzaro G, Sancesario GM, Colona VL, Scaricamazza E, Mercuri NB, Martorana A, Sancesario G. Schirinzi T, et al. J Neural Transm (Vienna). 2017 Dec;124(12):1621-1625. doi: 10.1007/s00702-017-1786-8. Epub 2017 Sep 2. J Neural Transm (Vienna). 2017. PMID: 28866757

8

Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia.

Petrillo S, Piermarini E, Pastore A, Vasco G, Schirinzi T, Carrozzo R, Bertini E, Piemonte F. Petrillo S, et al. Among authors: schirinzi t. Int J Mol Sci. 2017 Oct 18;18(10):2173. doi: 10.3390/ijms18102173. Int J Mol Sci. 2017. PMID: 29057804 Free PMC article.

9

Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus.

Schirinzi T, Sancesario GM, Di Lazzaro G, D'Elia A, Imbriani P, Scalise S, Pisani A. Schirinzi T, et al. J Neural Transm (Vienna). 2018 Apr;125(4):673-679. doi: 10.1007/s00702-018-1842-z. Epub 2018 Jan 20. J Neural Transm (Vienna). 2018. PMID: 29353355 Review.

10

ATP1A3-related epileptic encephalopathy responding to ketogenic diet.

Schirinzi T, Graziola F, Cusmai R, Fusco L, Nicita F, Elia M, Travaglini L, Bertini E, Curatolo P, Vigevano F, Capuano A. Schirinzi T, et al. Brain Dev. 2018 May;40(5):433-438. doi: 10.1016/j.braindev.2018.01.002. Epub 2018 Feb 1. Brain Dev. 2018. PMID: 29395663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page